Fig. 1From: In vitro susceptibility of clinical Clostridioides difficile isolates in Israel to metronidazole, vancomycin, fidaxomicin, ridinilazole and ibezapolstat,Distribution of C. difficile sequence types (STs) among study isolatesBack to article page